NDC 76348-694 - Clear Reflection Complexion
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76348-694
- Package NDCs from labels
- 76348-694-55
- Manufacturer
- RENU LABORATORIES, INC.
- Effective date
- 2021-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clear Reflection Complexion KIT | RENU LABORATORIES, INC. | 2021-08-19 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76348-694-55 | Clear Reflection Complexion | 53 g in 1 BOTTLE, PUMP | EMULSION | 1.1 g in 53 | 1 g in 53g | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eagle Brand Medicated Roll On Refresh | CAMPHOR, MENTHOL | Borden Company (Private) Limited | 567b6820-fb52-630e-e063-6294a90a8bf8 | 2015-07-01 | Warnings | AV092KU4JH 5TJD82A1ET |
| Eagle Brand Medicated Oil Aromatic | CAMPHOR, MENTHOL, METHYL SALICYLATE | Borden Company (Private) Limited | 54e45d89-e8c3-6fc3-e063-6394a90aac4e | 2015-06-15 | Warnings | 5TJD82A1ET |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 051f7347-5a76-4664-8fe2-e61b3dfcb0e4 | 2014-08-27 | XF417D3PSL | |
| SKIN MEDICA Purifying Foaming Wash | SALICYLIC ACID | Allergan, Inc. | 064d9e2b-077f-4229-b653-666fc5479ae2 | 2013-03-01 | Warnings | O414PZ4LPZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.